RGACX
Price
$70.07
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

RGACX vs RGAHX

Header iconRGACX vs RGAHX Comparison
Open Charts RGACX vs RGAHXBanner chart's image
American Funds Growth Fund of Amer R3
Price$70.07
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
RGACX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGACX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a StrongBuy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX (285B) and RGAHX (285B) have equal amount of cash in the bank . RGAHX pays higher dividends than RGACX: RGAHX (0.54) vs RGACX (0.08). RGACX was incepted earlier than RGAHX: RGACX (23 years) vs RGAHX (9 years). RGACX (0.94) is less costly to investors than RGAHX (0.44). RGACX (25.00) and RGAHX (25.00) have comparable annual turnover. RGACX (250) and RGAHX (250) have matching initial minimum investment requirements. RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. RGACX (2.58). RGAHX return over 5 years is better than : 44.87 vs. RGACX (41.87).
RGACXRGAHXRGACX / RGAHX
Total Expense Ratio0.940.44214%
Annual Report Gross Expense Ratio0.940.44214%
Fund Existence23 years9 years-
Gain YTD-2.667-2.478108%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets285B285B100%
Annual Yield % from dividends0.080.5416%
Returns for 1 year2.583.2579%
Returns for 3 years31.7033.4095%
Returns for 5 years41.8744.8793%
Returns for 10 years58.36N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics